Cargando…
Timp3 Deficient Mice Show Resistance to Developing Breast Cancer
Timp3 is commonly silenced in breast cancer, but mechanistic studies have identified both tumor promotion and suppression effects of this gene. We have taken a genetic approach to determine the impact of Timp3 loss on two mouse models of breast cancer. Interestingly, MMTV-PyMT Timp3(−⁄−) mice have d...
Autores principales: | Jackson, Hartland W., Hojilla, Carlo V., Weiss, Ashley, Sanchez, Otto H., Wood, Geoffrey A., Khokha, Rama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373869/ https://www.ncbi.nlm.nih.gov/pubmed/25807548 http://dx.doi.org/10.1371/journal.pone.0120107 |
Ejemplares similares
-
TIMP3 Regulates Mammary Epithelial Apoptosis with Immune Cell Recruitment Through Differential TNF Dependence
por: Hojilla, Carlo V., et al.
Publicado: (2011) -
Tumor suppression by stromal TIMPs
por: Shimoda, Masayuki, et al.
Publicado: (2016) -
Inflammation and breast cancer. Metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer
por: Hojilla, Carlo V, et al.
Publicado: (2008) -
Abnormal B-cell development in TIMP-deficient bone marrow
por: Weiss, Ashley, et al.
Publicado: (2021) -
Metalloprotease inhibitor TIMP proteins control FGF-2 bioavailability and regulate skeletal growth
por: Saw, Sanjay, et al.
Publicado: (2019)